Lys379
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Acetylation Site Page: > Lys379  -  Bcl-6 (human)

Site Information
ACNWKKYkFIVLNsL   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 460604

In vivo Characterization
Methods used to characterize site in vivo:
immunoprecipitation ( 1 ) , mutation of modification site ( 1 ) , western blotting ( 1 )
Disease tissue studied:
lymphoma ( 1 ) , B cell lymphoma ( 1 ) , Burkitt's lymphoma ( 1 ) , non-Hodgkin's lymphoma ( 1 ) , follicular lymphoma ( 1 )
Relevant cell line - cell type - tissue:

Downstream Regulation
Effects of modification on Bcl-6:
molecular association, regulation ( 1 )
Inhibit interaction with:
HDAC2 (human) ( 1 )

References 

1

Bereshchenko OR, Gu W, Dalla-Favera R (2002) Acetylation inactivates the transcriptional repressor BCL6. Nat Genet 32, 606-13
12402037   Curated Info